Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-16-088456
Filing Date
2016-03-16
Accepted
2016-03-16 16:03:10
Documents
77
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v434040_10k.htm 10-K 604438
2 EXHIBIT 10.23 v434040_ex10-23.htm EX-10.23 62011
3 EXHIBIT 23.1 v434040_ex23-1.htm EX-23.1 2355
4 EXHIBIT 31.1 v434040_ex31-1.htm EX-31.1 10174
5 EXHIBIT 31.2 v434040_ex31-2.htm EX-31.2 10360
6 EXHIBIT 32.1 v434040_ex32-1.htm EX-32.1 4797
  Complete submission text file 0001144204-16-088456.txt   5501449

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT iliu-20151231.xml EX-101.INS 1153107
8 XBRL TAXONOMY EXTENSION SCHEMA iliu-20151231.xsd EX-101.SCH 60891
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iliu-20151231_cal.xml EX-101.CAL 53865
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iliu-20151231_def.xml EX-101.DEF 362268
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE iliu-20151231_lab.xml EX-101.LAB 430301
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iliu-20151231_pre.xml EX-101.PRE 412236
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

EIN.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32715 | Film No.: 161509713
SIC: 2835 In Vitro & In Vivo Diagnostic Substances